Advertisement
Videos
Advertisement

New MS Drug Reduces Flare-Ups

Thu, 09/20/2012 - 4:30am

In clinical trials, the new drug, BG-12, has been shown to lower the number of nerve cell attacks with fewer side effects. It is expected to cost about $50,000 per year, the same as similar drugs.

 

Visit NBCNews.com for breaking news, world news, and news about the economy

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading